Liposomal Anticancer Drugs as Agents to be used in Combination with other Anticancer Agents: Studies on a Liposomal Formulation with two Encapsulated Drugs-Reference-Cited by-同舟云学术

Liposomal Anticancer Drugs as Agents to be used in Combination with other Anticancer Agents: Studies on a Liposomal Formulation with two Encapsulated Drugs

Published:1999-01 Issue:4 Volume:9 Page:507-522
ISSN:0898-2104
Container-title:Journal of Liposome Research
language:en
Short-container-title:Journal of Liposome Research

Author:

Saxon Dawn N.,Mayer Lawrence D.,Bally Marcel B.

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

http://www.tandfonline.com/doi/pdf/10.3109/08982109909035550

Reference33 articles.

1. Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial.

2. Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

3. Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA-Controlled Encapsulation of Small Molecules in Protein Nanoparticles;Journal of the American Chemical Society;2020-10-06

2. Combinatorial nanocarriers against drug resistance in hematological cancers: Opportunities and emerging strategies;Journal of Controlled Release;2019-02

3. Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft;Journal of Controlled Release;2013-12

4. Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy;Journal of Controlled Release;2012-06

5. Development, Characterization and In Vitro Evaluation of Single or Co-Loaded Imatinib Mesylate Liposomal Formulations;Journal of Nanoscience and Nanotechnology;2012-03-01